Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight into the commercial potential of the candidate once it is successfully developed and commercialized.
Roche (RHHBY - Analyst Report) specializes in cancer drugs. Immunotherapy has received a lot of attention in recent times as pharmaceuticals majors focus their research and development efforts on the same.